Concord Wealth Partners

Position in ZTS — Zoetis Inc.

CIK 1814214 ABINGDON, VA

Position in ZTS

as of Jun 30, 2026 · filed Jul 27, 2026 Compact

Position Value

$15,090

-$11,332 QoQ

Shares Held

210

0.0% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#1,220

of 1,412 holders

Holding Since

Dec 2020

21 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Concord Wealth Partners holds $46,411 across 4 Drug Manufacturers - Specialty & Generic names. ZTS ranks #2 (32.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VTRS	Viatris Inc	1,624	$25,789
2	ZTS	Zoetis Inc. This page	210	$15,090
3	TLRY	Tilray Brands, Inc.	1,200	$5,388
4	COLL	Collegium Pharmaceutical, Inc	4	$144

21 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$15,090	210	0.0%	Shares	Sole	2026-07-27
2025-12-31	$26,422	210	0.0%	Shares	Sole	2026-01-29
2025-09-30	$30,727	210	-48.5%	Shares	Sole	2025-11-05
2025-06-30	$63,627	408	+31.6%	Shares	Sole	2025-07-25
2025-03-31	$51,041	310	-6.3%	Shares	Sole	2025-05-02
2024-12-31	$53,929	331	-2.1%	Shares	Sole	2025-01-24
2024-09-30	$66,038	338	+9.0%	Shares	Sole	2024-10-24
2024-06-30	$53,741	310	0.0%	Shares	Sole	2024-07-31
2024-03-31	$52,455	310	-47.8%	Shares	Sole	2024-04-30
2023-12-31	$117,237	594	-2.9%	Shares	Sole	2024-04-30
2023-09-30	$106,475	612	-19.7%	Shares	Sole	2024-04-30
2023-06-30	$131,224	762	+48.0%	Shares	Sole	2023-08-08
2023-03-31	$85,716	515	-39.6%	Shares	Sole	2023-04-26
2022-12-31	$124,860	852	-1.3%	Shares	Sole	2023-01-30
2022-06-30	$148,341	863	-2.5%	Shares	Sole	2022-08-04
2022-03-31	$166,902	885	+4.9%	Shares	Sole	2022-04-20
2021-12-31	$205,961	844	+130.0%	Shares	Sole	2022-01-21
2021-09-30	$71,249	367	-50.7%	Shares	Sole	2021-11-09
2021-06-30	$138,651	744	-0.9%	Shares	Sole	2021-07-29
2021-03-31	$118,267	751	+16.6%	Shares	Sole	2021-05-13
2020-12-31	$106,582	644	—	Shares	Sole	2021-02-16
No filing history on record for this holder in this stock.